David Windley
Stock Analyst at Jefferies
(4.68)
# 803
Out of 4,644 analysts
804
Total ratings
59%
Success rate
9.6%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CI The Cigna Group | Downgraded: Hold | $330 → $307 | $273.87 | +12.10% | 65 | Aug 3, 2026 | |
| HUM Humana | Maintained: Buy | $235 → $624 | $372.82 | +67.37% | 69 | Jul 22, 2026 | |
| ELV Elevance Health | Maintained: Buy | $391 → $450 | $390.37 | +15.28% | 78 | Jul 16, 2026 | |
| MEDP Medpace Holdings | Downgraded: Hold | $490 → $515 | $605.50 | -14.95% | 35 | Jul 7, 2026 | |
| ICLR ICON Public Limited Company | Reiterated: Buy | $135 → $193 | $165.58 | +16.56% | 74 | Jun 25, 2026 | |
| CRL Charles River Laboratories International | Maintained: Buy | $225 | $282.00 | -20.21% | 75 | May 8, 2026 | |
| CNC Centene | Maintained: Hold | $43 → $39 | $64.88 | -39.89% | 88 | Apr 20, 2026 | |
| MOH Molina Healthcare | Maintained: Hold | $160 → $139 | $194.54 | -28.55% | 60 | Apr 20, 2026 | |
| UNH UnitedHealth Group | Maintained: Buy | $340 → $373 | $402.19 | -7.26% | 73 | Apr 20, 2026 | |
| OSCR Oscar Health | Upgraded: Hold | $12 → $16 | $27.97 | -42.80% | 7 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $365 → $295 | $351.37 | -16.04% | 42 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $18 | $21.05 | -16.86% | 15 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $225 → $255 | $243.84 | +4.58% | 59 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $20 | $19.11 | +2.04% | 14 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $9.5 | $19.52 | -51.33% | 3 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2.75 → $3 | $0.69 | +334.78% | 2 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $263 | $238.23 | n/a | 2 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $280 → $335 | $236.58 | n/a | 8 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 → $15 | $8.13 | n/a | 8 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $177 → $190 | $44.84 | n/a | 3 | Apr 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $200 → $248 | $6.81 | n/a | 5 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 → $8.5 | $4.90 | n/a | 10 | Aug 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $4.10 | n/a | 4 | Aug 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $129 | $356.46 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9.5 | $1.22 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $36 | $1.26 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $68 | $191.25 | n/a | 1 | Nov 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 | $49.21 | n/a | 1 | Aug 27, 2009 |
The Cigna Group
Aug 3, 2026
Downgraded: Hold
Price Target: $330 → $307
Current: $273.87
Upside: +12.10%
Humana
Jul 22, 2026
Maintained: Buy
Price Target: $235 → $624
Current: $372.82
Upside: +67.37%
Elevance Health
Jul 16, 2026
Maintained: Buy
Price Target: $391 → $450
Current: $390.37
Upside: +15.28%
Medpace Holdings
Jul 7, 2026
Downgraded: Hold
Price Target: $490 → $515
Current: $605.50
Upside: -14.95%
ICON Public Limited Company
Jun 25, 2026
Reiterated: Buy
Price Target: $135 → $193
Current: $165.58
Upside: +16.56%
Charles River Laboratories International
May 8, 2026
Maintained: Buy
Price Target: $225
Current: $282.00
Upside: -20.21%
Centene
Apr 20, 2026
Maintained: Hold
Price Target: $43 → $39
Current: $64.88
Upside: -39.89%
Molina Healthcare
Apr 20, 2026
Maintained: Hold
Price Target: $160 → $139
Current: $194.54
Upside: -28.55%
UnitedHealth Group
Apr 20, 2026
Maintained: Buy
Price Target: $340 → $373
Current: $402.19
Upside: -7.26%
Oscar Health
Apr 20, 2026
Upgraded: Hold
Price Target: $12 → $16
Current: $27.97
Upside: -42.80%
Feb 10, 2026
Maintained: Buy
Price Target: $365 → $295
Current: $351.37
Upside: -16.04%
Feb 10, 2026
Maintained: Hold
Price Target: $21 → $18
Current: $21.05
Upside: -16.86%
Feb 6, 2026
Maintained: Buy
Price Target: $225 → $255
Current: $243.84
Upside: +4.58%
Nov 20, 2025
Maintained: Buy
Price Target: $16 → $20
Current: $19.11
Upside: +2.04%
Sep 8, 2025
Maintained: Hold
Price Target: $21 → $9.5
Current: $19.52
Upside: -51.33%
Aug 25, 2025
Maintained: Hold
Price Target: $2.75 → $3
Current: $0.69
Upside: +334.78%
Jun 4, 2025
Maintained: Hold
Price Target: $263
Current: $238.23
Upside: n/a
Jun 2, 2025
Maintained: Buy
Price Target: $280 → $335
Current: $236.58
Upside: n/a
Apr 21, 2025
Maintained: Hold
Price Target: $16 → $15
Current: $8.13
Upside: n/a
Apr 26, 2021
Maintained: Buy
Price Target: $177 → $190
Current: $44.84
Upside: n/a
Feb 25, 2021
Maintained: Hold
Price Target: $200 → $248
Current: $6.81
Upside: n/a
Aug 4, 2020
Rated: Hold
Price Target: $7 → $8.5
Current: $4.90
Upside: n/a
Aug 21, 2017
Reiterated: Buy
Price Target: $28
Current: $4.10
Upside: n/a
Dec 2, 2016
Reiterated: Buy
Price Target: $129
Current: $356.46
Upside: n/a
Dec 2, 2016
Reiterated: Hold
Price Target: $9.5
Current: $1.22
Upside: n/a
Dec 2, 2016
Reiterated: Hold
Price Target: $36
Current: $1.26
Upside: n/a
Nov 28, 2016
Reiterated: Hold
Price Target: $68
Current: $191.25
Upside: n/a
Aug 27, 2009
Downgraded: Hold
Price Target: $12
Current: $49.21
Upside: n/a